STATE STREET CORP - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 3 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 8.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$87,888
+41.0%
195,089
-9.3%
0.00%
Q1 2023$62,347
-67.8%
214,989
-50.0%
0.00%
Q4 2022$193,448
+130.3%
429,978
+170.4%
0.00%
Q3 2022$84,000
+5.0%
158,9890.0%0.00%
Q2 2022$80,000
-95.6%
158,989
-79.8%
0.00%
Q1 2022$1,810,000
-49.7%
787,048
+3.8%
0.00%
Q4 2021$3,601,000
-40.9%
758,041
-1.2%
0.00%
Q3 2021$6,097,000
+15.6%
766,941
+1.2%
0.00%
Q2 2021$5,272,000
-7.3%
757,500
+5.4%
0.00%
Q1 2021$5,690,000
-0.6%
718,475
-1.2%
0.00%
Q4 2020$5,724,000
+22.9%
727,334
+10.7%
0.00%
Q3 2020$4,657,000
-22.9%
656,851
+0.6%
0.00%
Q2 2020$6,038,000
+174.7%
652,803
+38.4%
0.00%
Q1 2020$2,198,000
-38.1%
471,698
+1.5%
0.00%
Q4 2019$3,551,000
+7.0%
464,799
+7.7%
0.00%
Q3 2019$3,320,000
+26.1%
431,706
+12.3%
0.00%
Q2 2019$2,632,000
+33.5%
384,270
+56.8%
0.00%
Q1 2019$1,972,000
+7.0%
245,029
-0.4%
0.00%
Q4 2018$1,843,000
-22.6%
246,040
-1.0%
0.00%
Q3 2018$2,380,000
+0.6%
248,512
+11.2%
0.00%
Q2 2018$2,366,000223,5370.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Yu Fan 112,044$532,0006.17%
Aisling Capital Management LP 1,691,151$8,033,0002.83%
Bain Capital Life Sciences Investors, LLC 2,847,689$13,527,0001.07%
GREAT POINT PARTNERS LLC 910,251$4,324,0000.96%
Samsara BioCapital, LLC 883,720$4,198,0000.81%
Sio Capital Management, LLC 498,500$2,368,0000.71%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$1,167,0000.53%
Nantahala Capital Management 2,813,560$13,364,0000.47%
Altium Capital Management LP 293,764$1,395,0000.38%
Lion Point Capital, LP 300,000$1,425,0000.38%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders